⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Future Health Biobank and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Future Health Biobank
↗Nottingham, United Kingdom
Future Health Biobank is a multinational biotechnology company specializing in the collection, processing, and long-term cryopreservation of stem cells from umbilical cord blood, cord tissue, and dental pulp. Founded in 2002, it is one of the world's most accredited stem cell banks, supporting over 100,000 families across 94 countries.
Beyond stem cell banking, the company has expanded its services to include genetic screening, non-invasive prenatal testing (NIPT), and newborn screening. It operates with multiple international accreditations, including Human Tissue Authority (HTA) licensing in the UK and Health Canada CTO registration, maintaining high standards for laboratory security and disaster recovery.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Stem Cell Banking & Genetic Testing
SIZE & FINANCIALS
Employees:51-200
Founded:2002
Ownership:private
Status:operating
PIPELINE
Modalities:Stem cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Future Health Technologies, Futurecells FZ-LLC
Key Partnerships:Various international hospitals and research institutions for sample storage and collection
COMPETITION
Position:Leader
Competitors:Cord Blood Registry (CBR), ViaCord, Cryo-Cell International
LEADERSHIP
Key Executives:
Chris Bond - Chief Executive Officer
LINKS
Website:fhbb.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Future Health Biobank. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.